Forward Lymphoma Research Projects
Sponsorships for research projects start at $50,000 and are immediately applied to research projects to advance treatments and find a cure for lymphoma. If you would like to sponsor a study on lymphoma research, please contact: Ron Skoronski at (608) 516-0389 ron@forwardlymphoma.org
Treanda Effective In Indolent Non-Hodgkin's Lymphoma Trial
Dr Brad Kahl, lead investigator of the study, and Associate Professor, Director Lymphoma Service, University of Wisconsin Paul P Carbone Comprehensive Cancer Center, said that: "The high response rate in this study suggest that bendamustine [Treanda] could offer substantial periods of remission to patients with indolent NHL whose cancer is progressing after treatment with rituximab."
For the full article, visit Medical News Today.
The following projects are currently funded by Forward Lymphoma donations:
Research Project - Identification of Biomarkers
Researcher: Brad Kahl
Description:
Use of Quantitative Immunohistochemistry for Identification of Biomarkers with Prognostic and Therapeutic Significance in Mantle Cell Lymphoma
Research Project - Assessment of bcl-2 Family
Researchers: Catherine Leith & Julie Chang
Description:
Assessment of the bcl-2 Family of Regulatory Proteins Expresses by Quantitative Immunohistochemistry in Follicular Lymphoma
Research Project - Tumor Microenvironment
Researcher: Peiman Hematti
Description:
Immunosuppressive Effects of Tumor microenvironment in B-cell Lymphomas
Research Project - Signaling Pathway
Researcher: Erik Ranheim
Description:
The Frizzled / Wnt Signaling Pathway in B Cell Lymphoma / Leukemia Activating Innate Anti-tumor Immunity in B Cell Lymphoma / Leukemia
Get More from Forward Lymphoma
Sign up to receive more information from Forward Lymphoma and the Carbone Cancer Center.
Download the Helping Lymphoma Patients with Research Focused on Psychological Recovery white paper.
Download the Determining Who is Right for Rituximab white paper.
Download the Using Stem Cells to Develop Patient Specific Treatments white paper.
